EX

EXACT Sciences

- NASDAQ:EXAS
Last Updated 2024-04-16
  • Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting

  • Locations

    • Madison WI

  • Total Funding (USD)

    8.2 million

  • Acquisitions (4)

    • Genomic Health (2019)
    • Biomatrica (2018)
    • Armune BioScience (2018)
    • Sampleminded (2017)

  • Security

    Type: ORD
    CUSIP: 30063P105
    ISIN: US30063P1057
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo.old 2019-09-24
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo